🔗 Share this article

A shadow market for unlicensed weight-loss drugs is propelled by TikTok fitness influencers and sellers on messaging platforms, based on new investigations.

Investigational Treatment Acquiring Traction Online

The experimental drug, which is still in clinical trials, is being promoted by online personalities for its supposed fat-burning properties. Followers are urged to contact these accounts directly for source information, while also receiving promotional offers.

Active Commerce on Messaging Platforms

Separately, a flourishing trade exists on messaging services, where groups with numerous of participants share comparison photos, injection guides and claims of rapid UK delivery. Vendors promote the drug there before directing buyers to other platforms for transactions.

Learning About Retatrutide

Retatrutide is an investigational injection developed by US drugmaker Eli Lilly. The treatment affects three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials indicate it could assist patients reduce up to a quarter of their total weight. Nicknamed the “triple G”, the drug is being promoted online as the successor to Ozempic.

Healthcare Professionals Express Concerns

Nevertheless, doctors and chemists have warned that the distribution of what remains an unlicensed drug in the UK is worrisome and could lead to individuals injecting substances of uncertain source.

Some professionals stated the demand for retatrutide could be linked to the increasing price of approved weight loss products such as Mounjaro.

Legal Status and Implementation

Marketing the unapproved drug on TikTok or Telegram is prohibited in the UK, as it is an unapproved medication that cannot be promoted or distributed for human use under the Human Medicines Regulations 2012.

Several content creators attempt to sidestep the rules by referring to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted substance, but advertising and supply can still violate pharmaceutical, advertising, and consumer regulations, risking penalties, prosecution or prison.

Platform Reaction and Content Elimination

According to TikTok, the platform has removed violative content and banned associated keywords and search suggestions. The organization stated it was dedicated to maintaining the service secure and investing in strengthening enforcement strategies.

Online Marketplace Activities

Investigations also found groups with up to nine thousand members marketing retatrutide using Telegram's integrated search feature, which operates like a online catalog. Entering “retatrutide” immediately displays channels with thousands of users, populated with images of weight loss, positive reviews and step-by-step guides for mixing or injecting at home.

After minutes of entering one group, a vendor shared contact information, where most purchases take place. The seller sent an instruction manual and promised shipping within 48 hours. When questioned whether the product was genuine, one seller said: “You can’t be sure.” Another shared a image of a supposed testing documentation. Not one inquired about body mass, medical conditions or previous experience.

Item Details and Pricing

Inside these communities, messages show black plastic packages with Royal Mail stickers, stating to include fresh supplies. One message read: “It took eight of us to load them this morning.”

Customers can choose between powder vials, prepared at residence with purified liquid, or ready-to-use pens typically sold at £160 for 20 milligrams. When questioned how much time a injector should be used, vendors give contradictory answers varying between a few weeks to “depends on your body”.

Service Moderation and Safety Measures

A spokesperson for the messaging service stated it regularly monitored dangerous material on its platform including material that encouraged the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“Individuals are injecting substances they can’t verify. Although the science behind retatrutide is valid, these online products may not include what they claim,” said Jason Murphy, the head of pharmacy at a pharmacy service.

Dr Crystal Wyllie of an online medical service linked the increase in interest to recent price rises for approved slimming drugs such as Mounjaro. “With costs rising, individuals are using online platforms. But fake injections are extremely risky. You can’t be certain what’s contained or whether the conditions they were made in was sterile,” she explained.

Her team has already seen patients harmed by self-injection from unverified sources. “We understand the disappointment, but purchasing from messaging apps or WhatsApp is gambling with your health,” said Wyllie. “These substances could be impure or incorrectly dosed.”

Manufacturer Position

A representative from the pharmaceutical company said the substance was in phase 3 research studies and had not been evaluated or approved by any government authority anywhere in the world. “Consequently at this time no one can sell [it] for human use,” they explained, noting that any product “falsely representing itself as a company investigational substance not yet authorized … may subject patients to possibly significant health risks”.